← Browse by Condition
Medical Condition
prurigo nodularis
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3
NCT05316805
Recruiting
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Enrollment
100,000 pts
Location
China
Sponsor
Peking University First Hospit...
NCT06516965 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
Enrollment
330 pts
Location
United States, Austr...
Sponsor
Incyte Corporation
NCT06087627
Recruiting
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
Enrollment
150 pts
Location
Germany
Sponsor
Sanofi
NCT06779136 Phase 3
Recruiting
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Enrollment
160 pts
Location
China
Sponsor
Shanghai Mabgeek Biotech.Co.Lt...